The FDA has requested additional information from HygeiaPharmaceuticals Inc. under its investigational new drugapplication (IND) for Phase I testing of Monopharm-C to treatcolorectal cancer.

Hygeia of San Diego said a response should be complete by theend of July, clearing the way for a final agreement within 30days and commencement of trials immediately thereafter.

(c) 1997 American Health Consultants. All rights reserved.